Australian firm Telix Pharmaceuticals acquires US radiopharmacy network RLS (USA) Inc. for $250M to expand North American manufacturing and distribution.

Telix Pharmaceuticals, an Australian firm, is acquiring RLS (USA) Inc., a leading U.S. radiopharmacy network, to enhance its North American manufacturing and distribution capabilities. This $250 million deal adds 31 licensed pharmacies and over 100,000 square feet of production space, allowing Telix to deploy its ARTMS QUANTM Irradiation System for efficient radiometal production. The move aims to strengthen supply chains and broaden patient access across the U.S. market.

September 23, 2024
10 Articles

Further Reading